For 50 years, Robert L. DuPont, MD has been a leader in substance use disorder treatment and prevention. He was the first Director of the U.S. National Institute on Drug Abuse (1973-1978) and the second White House Drug Chief (1973-1977). From 1968-1970 he was Director of Community Services for the District of Columbia Department of Corrections. From 1970-1973, he served as Administrator of the District of Columbia Narcotics Treatment Administration. In 1978 he became the founding President of the Institute for Behavior and Health, Inc., a non-profit research and policy organization that identifies and promotes powerful new ideas to reduce drug use and addiction.
A graduate of Emory University, Dr. DuPont received an MD degree in 1963 from the Harvard Medical School. He completed his psychiatric training at Harvard and the National Institutes of Health in Bethesda, Maryland. Dr. DuPont maintains an active practice of psychiatry specializing in addiction and the anxiety disorders and has been Clinical Professor of Psychiatry at the Georgetown University School of Medicine since 1980. His most recent book is Chemical Slavery: Understanding Addiction and Stopping the Drug Epidemic.
Caroline DuPont, MD
Dr. DuPont is Vice President of the Institute for Behavior and Health, Inc. (IBH), a 501(c)3 non-profit research and policy organization located in Rockville, MD. In her role as Vice President, Caroline DuPont, MD focuses on the areas of addiction treatment and prevention. She maintains a private practice specializing in anxiety and addiction.
Formerly she was the founding President and Principal Investigator of DuPont Clinical Research, Inc., where she directed a team that conducted studies of investigational medication for the anxiety and affective disorders.
Dr. DuPont received her MD from the University of Texas Health Sciences Center, Houston and completed her training at the Johns Hopkins Hospital, Baltimore, where for years she held an appointment on the clinical faculty of psychiatry. She is board certified by the American Board of Psychiatry and Neurology and by the American Board of Addiction Medicine. She is the co-author of numerous publications and several book chapters on anxiety and addiction.
Is vaping helping people quit smoking or creating new smokers? In a simulation model, scientists calculated 3000 years of life gained in smokers who...
Cannabis has many different chemicals, namely cannabinoids that have pharmaceutical benefits. Learn about FDA approved cannabinoid research. There is a big difference between medications...
Listen to Dr. Nora Volkow’s discussion with Dr. Roneet Lev on the gold standard for addiction, substance use disorder treatment, innovations in drug treatment,...